Teratogenicity Screening
Teratogenicity Screening is a systematic assessment method used in developmental toxicology to identify substances that induce structural or functional abnormalities in embryonic or fetal development, thereby distinguishing potential teratogens from non-teratogenic agents.
285
Publications
13.1K
Citations
907
Authors
331
Institutions
Publications per year
2017–2026
25
Parents
285
907
14
h-index
13
h-index
9
h-index
8
h-index
7
h-index
1–5 of 907
331

Oklahoma State University
Stillwater, United States
14 h-index
37 publications
2.4K citations
Environmental Protection Agency
Washington, United States
12 h-index
22 publications
1.2K citations

Research Triangle Park Foundation
Durham, United States
9 h-index
17 publications
906 citations
National Institute of Environmental Health Sciences
Durham, United States
8 h-index
18 publications
1.2K citations
Bristol-Myers Squibb (Germany)
Munich, Germany
6 h-index
17 publications
1.8K citations
Bristol-Myers Squibb (United States)
New York, United States
6 h-index
25 publications
2.8K citations
University of Washington
Seattle, United States
6 h-index
7 publications
349 citations

Centers for Disease Control and Prevention
Atlanta, United States
4 h-index
9 publications
234 citations
1–8 of 331
28 publications · 1.3K citations
21
h-index
21 publications · 889 citations
17
h-index
Repository · 21 publications · 641 citations
17
h-index
13 publications · 417 citations
13
h-index
11 publications · 710 citations
11
h-index
1–5